• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HetFHMM:一种使用因子隐马尔可夫模型推断肿瘤异质性的新方法。

HetFHMM: A Novel Approach to Infer Tumor Heterogeneity Using Factorial Hidden Markov Models.

作者信息

Rahman Mohammad S, Nicholson Ann E, Haffari Gholamreza

机构信息

Clayton School of Information Technology, Monash University , Clayton, Australia .

出版信息

J Comput Biol. 2018 Feb;25(2):182-193. doi: 10.1089/cmb.2017.0101. Epub 2017 Oct 16.

DOI:10.1089/cmb.2017.0101
PMID:29035575
Abstract

Cancer arises from successive rounds of mutations, resulting in tumor cells with different somatic mutations known as clones. Drug responsiveness and therapeutics of cancer depend on the accurate detection of clones in a tumor sample. Recent research has considered inferring clonal composition of a tumor sample using computational models based on short read data of the sample generated using next-generation sequencing (NGS) technology. Short reads (segmented DNA parts of different tumor cells) are noisy; therefore, inferring the clones and their mutations from the data is a difficult and complex problem. We develop a new model called HetFHMM, based on factorial hidden Markov models, to infer clones and their proportions from noisy NGS data. In our model, each hidden chain represents the genomic signature of a clone, and a mixture of chains results in the observed data. We make use of Gibbs sampling and exponentiated gradient algorithms to infer the hidden variables and mixing proportions. We compare our model with strong models from previous work (PyClone and PhyloSub) based on both synthetic data and real cancer data on acute myeloid leukemia. Empirical results confirm that HetFHMM infers clonal composition of a tumor sample more accurately than previous work.

摘要

癌症源于连续的多轮突变,产生具有不同体细胞突变的肿瘤细胞,即克隆。癌症的药物反应性和治疗方法取决于肿瘤样本中克隆的准确检测。最近的研究考虑使用基于下一代测序(NGS)技术生成的样本短读数据的计算模型来推断肿瘤样本的克隆组成。短读(不同肿瘤细胞的分段DNA部分)存在噪声;因此,从数据中推断克隆及其突变是一个困难且复杂的问题。我们基于因子隐马尔可夫模型开发了一种名为HetFHMM的新模型,以从有噪声的NGS数据中推断克隆及其比例。在我们的模型中,每个隐藏链代表一个克隆的基因组特征,链的混合产生观测数据。我们利用吉布斯采样和指数梯度算法来推断隐藏变量和混合比例。我们基于合成数据和急性髓系白血病的真实癌症数据,将我们的模型与先前工作中的强大模型(PyClone和PhyloSub)进行比较。实证结果证实,HetFHMM比先前工作更准确地推断肿瘤样本的克隆组成。

相似文献

1
HetFHMM: A Novel Approach to Infer Tumor Heterogeneity Using Factorial Hidden Markov Models.HetFHMM:一种使用因子隐马尔可夫模型推断肿瘤异质性的新方法。
J Comput Biol. 2018 Feb;25(2):182-193. doi: 10.1089/cmb.2017.0101. Epub 2017 Oct 16.
2
Analyzing Tumor Heterogeneity by Incorporating Long-Range Mutational Influences and Multiple Sample Data into Heterogeneity Factorial Hidden Markov Model.通过将远程突变影响和多样本数据纳入异质性因子隐马尔可夫模型来分析肿瘤异质性
J Comput Biol. 2019 Sep;26(9):985-1002. doi: 10.1089/cmb.2018.0242. Epub 2019 May 23.
3
CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.CLImAT-HET:从全基因组测序数据中检测异质性肿瘤样本中的亚克隆拷贝数改变和杂合性缺失
BMC Med Genomics. 2017 Mar 15;10(1):15. doi: 10.1186/s12920-017-0255-4.
4
Hidden Markov Models in Bioinformatics: SNV Inference from Next Generation Sequence.生物信息学中的隐马尔可夫模型:从下一代测序中推断单核苷酸变异
Methods Mol Biol. 2017;1552:123-133. doi: 10.1007/978-1-4939-6753-7_9.
5
Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.最新基因组测序研究突显的急性髓系白血病的克隆进化
Oncotarget. 2016 Sep 6;7(36):58586-58594. doi: 10.18632/oncotarget.10850.
6
Inferring clonal evolution of tumors from single nucleotide somatic mutations.从单核苷酸体细胞突变推断肿瘤的克隆进化。
BMC Bioinformatics. 2014 Feb 1;15:35. doi: 10.1186/1471-2105-15-35.
7
Reconstructing tumor clonal heterogeneity and evolutionary relationships based on tumor DNA sequencing data.基于肿瘤 DNA 测序数据重建肿瘤克隆异质性和进化关系。
Brief Bioinform. 2024 Sep 23;25(6). doi: 10.1093/bib/bbae516.
8
High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics.利用液滴微流控技术对急性髓系白血病肿瘤进行高通量单细胞 DNA 测序。
Genome Res. 2018 Sep;28(9):1345-1352. doi: 10.1101/gr.232272.117. Epub 2018 Aug 7.
9
Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia.单细胞基因分型揭示急性髓系白血病中复杂的克隆多样性。
Sci Transl Med. 2015 Apr 1;7(281):281re2. doi: 10.1126/scitranslmed.aaa0763.
10
Genetic heterogeneity and clonal evolution in acute myeloid leukemia.急性髓系白血病中的遗传异质性与克隆进化
Curr Opin Hematol. 2021 Jan;28(1):64-70. doi: 10.1097/MOH.0000000000000626.

引用本文的文献

1
vmrseq: probabilistic modeling of single-cell methylation heterogeneity.vmrseq:单细胞甲基化异质性的概率建模
Genome Biol. 2024 Dec 30;25(1):321. doi: 10.1186/s13059-024-03457-7.
2
Computational Reconstruction of Clonal Hierarchies From Bulk Sequencing Data of Acute Myeloid Leukemia Samples.从急性髓系白血病样本的批量测序数据中进行克隆层次结构的计算重建
Front Physiol. 2021 Aug 23;12:596194. doi: 10.3389/fphys.2021.596194. eCollection 2021.
3
Using Advanced Statistical Models to Predict the Non-Communicable Diseases.使用高级统计模型预测非传染性疾病。
Iran J Public Health. 2015 Dec;44(12):1714-5.